Antidepressants and the gut: What to know, according to experts

Evan Walker
Evan Walker TheMediTary.Com |
collage of bacteria close-up image and black and white photo of person's hand holding pillsShare on Pinterest
How do antidepressants impact gut Health? Three experts explain the facts. Design by MNT; Photography by Fiordaliso/Getty Images & STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY/Getty Images.
  • Growing evidence shows that the gut microbiome is important for immune, digestive, and overall Health.
  • Because antidepressants are taken orally, some of the active ingredients may make it to the large intestine, where the majority of microbes live.
  • Medical News Today had spoken to three medical experts to find out more about how commonly prescribed antidepressants could shape and reshape our gut.

Recently, interest has been growing in how antidepressants could impact the gut microbiome — the trillions of microorganisms that inhabit the gut.

A recent study, for instance, concluded that antidepressants, among other drugs, impact the gut microbiome for years.

On the other side of the coin, scientists now know that connections between the gut microbiome and brain (the gut-microbiota-brain axis) can influence mental Health.

This raises the intriguing possibility that the makeup of the gut microbial community might influence how well antidepressant drugs work.

For this article, Medical News Today contacted three medical experts to explore how antidepressants might influence the microbiome. We also investigate how the gut microbiome influences the efficacy of antidepressant treatment.

In particular, we will focus on selective serotonin-reuptake inhibitors (SSRIs), which are the most commonly prescribed antidepressants.

It is crucial to note, however, that anyone taking antidepressants should not stop their medication or change their treatment regiment before speaking with their doctor. Doing so can be dangerous.

Although in some ways this seems like a relatively easy question to answer, there is an extra twist that makes it more challenging.

Existing research has shown that people with major depressive disorder have a different microbiome makeup than individuals without the condition.

This means that simply analyzing the gut microbiome of people who are taking SSRIs cannot tell you the full story: Their gut bacteria were probably different before they took the drugs.

Some studies have investigated the microbiomes of individuals taking SSRIs and other depression medications, identifying changes in the levels of certain species. However, these studies only looked at the microbiome at one point in time, so it is not possible to know whether these differences were present before the individual started taking SSRIs.

To make things more complex still, even though studies have identified differences between the microbiomes of individuals with and without depression, there is not yet a consensus on the precise differences.

Still, an innovative study from 2021 provides some insights. The scientists recruited 30 people with major depressive disorder and 30 healthy controls. Those with depression were drug naive, meaning that they had not previously taken SSRIs.

The researchers took stool samples before the participants began treatment and after their symptoms began responding to treatment. This allowed them to chart the changes associated with the medication, specifically.

Overall, the researchers concluded that SSRIs did change the gut microbiome of people with depression. By the end of the study, their gut microbiome was more like the microbiome of healthy controls.

Although questions remain, this suggests that the changes in gut bacteria are not necessarily negative. The authors wrote: “[T]he gut microbiota tended to ‘normal’ gut microbiota structure under SSRIs treatment, thus indicating a positive effect of SSRIs on the change of gut microbiota.”

However, scientists need to continue investigating, as it is well-established that some SSRIs have an antibacterial action.

Although SSRIs can be a game-changer for some people with depression, they do not work for everyone. An estimated four out of 10 people with depression who take these drugs do not experience benefits.

Some evidence suggests that the makeup of an individual’s gut microbiome may help determine whether someone will respond well to SSRIs or not.

One study compared 62 antidepressant-naive people with major depressive disorder with 41 matched, Healthy controls. Once again, the researchers noted differences between the microbiomes of the two groups.

After those in the depression group had undergone 8 weeks of treatment with SSRIs, the scientists then divided them into responders who benefited and nonresponders who did not.

They found that some common genera of gut microbes were present at greater levels in those who did respond to treatment compared with nonresponders:

  • Blautia—these are associated with health benefits and can kill certain disease-causing bacteria
  • Bifidobacterium — these bacteria support a healthy gut and immune system
  • Coprococcus — these produce a short-chain fatty acid called butyrate, which is associated with good overall health; interestingly, low levels of this genus of bacteria are associated with depression.

“Emerging evidence suggests a real, two-way relationship. The microbiome doesn’t just respond to antidepressants; it may also help determine how well they work,“ Singh told MNT.

“Several studies have found that people with more diverse, balanced gut microbiomes tend to respond better to antidepressants. It’s an exciting area of research,” continued Singh, “and while we’re not yet at the point of choosing medications based on stool samples, the link between gut health and antidepressant response is becoming harder to ignore.”

Share this Article